secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2026-08-20T11:43:35+00:00
Accession:  0001213900-26-091893
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fortitude Q2 revenue $20.9M, adj EBITDA $8.5M; buys 9.4% HSCS stake ahead of merger
--------------------------------------------------------------------------------

- Fortitude Q2 2026 revenue $20.9M; adjusted EBITDA $8.5M.
- Mined ~33,646 ZEC at 4.0 GSol/s avg hash rate; 60+ MW across 7 sites.
- On Aug 12, 2026 Fortitude bought 411,522 HSCS shares at $2.43 VWAP (22% premium), now owns ~9.4%.
- Proposed merger with HeartSciences expected to close H2 2026; exchange ratio unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026091893/0001213900-26-091893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026091893/ea0302835-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-091893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer